# Helius Medical Technologies (HSDT) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/HSDT
## Company Profile
- Ticker: HSDT
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: CNS
## Stock Data
- Close: 2.65 USD
- Market cap: 93418680 USD
- Last updated: 2026-10-05
## Business Overview
### Solana Digital-Asset Company
Solana Company, formerly Helius Medical Technologies, operates a digital-asset treasury and infrastructure strategy centered on the Solana ecosystem. It has sold the legacy PoNS neuromodulation business.
### Solana Treasury Strategy
The company acquires and holds SOL as a primary treasury asset. Its economic exposure includes changes in token value as well as potential staking rewards and other ecosystem-based returns.
### Validator Infrastructure
Solana Company intends to participate in blockchain validation and related infrastructure. Validator operations can support network security while generating protocol rewards and service-based economics.
### Ecosystem Advisory Activities
The company also plans advisory and strategic services for participants building within the Solana network. These activities may include treasury, infrastructure, partnerships, and institutional adoption.
### Exit from PoNS
The sale of the Portable Neuromodulation Stimulator business ended the company's direct operating focus on neurorehabilitation devices. Future performance is therefore primarily linked to digital assets and blockchain execution.
## Why The Stock Is Moving

As of Oct 5, 2026, HSDT closed up 0.76% at $2.65. No new same-company headline was identified in the current news window.

## Recent News
- 2024-10-18 12:00 EST — [Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference](https://biopharmsignal.com/news/HSDT/helius-medical-technologies-inc-to-present-at-the-2024-thinkequity-conference-50f2ae4b) — Source: Helius Medical Technologies
- 2019-02-11 13:00 EST — [Uptick Newswire Hosts Helius Medical Technologies, Inc. on the Stock Day Podcast to Discuss the Company’s Clearance in Canada and Expansion into The United States and Europe](https://biopharmsignal.com/news/HSDT/uptick-newswire-hosts-helius-medical-technologies-inc-on-the-stock-day-podcast-t-a626f173) — Source: Helius Medical Technologies